You may also like
Is Platelet Function as Measured by Thrombelastograph Monitoring in Whole Blood Affected by Platelet Inhibitors?
Platelet inhibitors, especially the glycoprotein (GP) IIb/IIIa receptor antagonists, have demonstrated their effectiveness in reducing the acute ischemic complications of percutaneous coronary intervention (PCI) and in improving clinical outcomes in patients with acute coronary crisis.
1 min read
Potential for Stem Cell Use in Congenital Heart Disease
This article reports on the evolving field of stem cell therapy and its impact on the management of cardiac pathology, in particular congenital heartdisease.
1 min read
Insulin-Blood Cardioplegia Decreases Matrix Metalloproteinase Activity in Ischaemia-Reperfusion Injury During Coronary Artery Bypass Surgery
This is the first open heart surgery study in which diminished MMP activation was achieved via a metabolic change.
1 min read
